AHA Science
@ahascience.bsky.social
The official account for American Heart Association meetings, science news, funding opportunities and membership.
ICYMI here are results from all 17 LBS presentations at #AHA25. Missed them?
Check them out on Scientific Sessions OnDemand coming in early December.
Check them out on Scientific Sessions OnDemand coming in early December.
November 18, 2025 at 3:23 PM
ICYMI here are results from all 17 LBS presentations at #AHA25. Missed them?
Check them out on Scientific Sessions OnDemand coming in early December.
Check them out on Scientific Sessions OnDemand coming in early December.
Advance your research with the support you deserve. We anticipate that about 1,000 grants will be awarded this year to help you advance science and save lives. Applications are open now.
November 12, 2025 at 1:00 AM
Advance your research with the support you deserve. We anticipate that about 1,000 grants will be awarded this year to help you advance science and save lives. Applications are open now.
The TOP trial is a parallel, single-blind, randomized, clinical superiority trial, N=1424 that sought to determine whether liberal versus restrictive transfusion strategy after major general and vascular surgery reduces adverse outcomes in high cardiac risk patients.
Sunil Rao, MD on the results.
Sunil Rao, MD on the results.
November 9, 2025 at 9:35 PM
The TOP trial is a parallel, single-blind, randomized, clinical superiority trial, N=1424 that sought to determine whether liberal versus restrictive transfusion strategy after major general and vascular surgery reduces adverse outcomes in high cardiac risk patients.
Sunil Rao, MD on the results.
Sunil Rao, MD on the results.
November 9, 2025 at 3:11 PM
In patients with AF who are stable beyond one year of drug-eluding stent implantation NOAC monotherapy provides a simple and safe long-term therapy versus combination therapy.
November 9, 2025 at 12:02 PM
In patients with AF who are stable beyond one year of drug-eluding stent implantation NOAC monotherapy provides a simple and safe long-term therapy versus combination therapy.
📢 Adding evolocumab to lipid-lowering therapy significantly reduced the risk of a first major CV event in patients without prior heart attack or stroke.
#AHA25 ⬇️
#AHA25 ⬇️
November 8, 2025 at 11:03 PM
📢 Adding evolocumab to lipid-lowering therapy significantly reduced the risk of a first major CV event in patients without prior heart attack or stroke.
#AHA25 ⬇️
#AHA25 ⬇️
The study demonstrates that DR10624 can lead to significant reductions in triglycerides with favorable safety and tolerability results.
Shayan Mohammadmoradi's, MS, PhD take on the data presented at #AHA25
Shayan Mohammadmoradi's, MS, PhD take on the data presented at #AHA25
November 8, 2025 at 9:36 PM
The study demonstrates that DR10624 can lead to significant reductions in triglycerides with favorable safety and tolerability results.
Shayan Mohammadmoradi's, MS, PhD take on the data presented at #AHA25
Shayan Mohammadmoradi's, MS, PhD take on the data presented at #AHA25
November 8, 2025 at 9:06 PM
📢 #ISC26 CFA submission deadline extended
Your research deserves the spotlight—submit your International Stroke Conference abstract by Oct. 30 at 11:59 p.m. ET.
Don’t miss your chance to share your science on the world stage.
Your research deserves the spotlight—submit your International Stroke Conference abstract by Oct. 30 at 11:59 p.m. ET.
Don’t miss your chance to share your science on the world stage.
October 30, 2025 at 3:44 PM
📢 #ISC26 CFA submission deadline extended
Your research deserves the spotlight—submit your International Stroke Conference abstract by Oct. 30 at 11:59 p.m. ET.
Don’t miss your chance to share your science on the world stage.
Your research deserves the spotlight—submit your International Stroke Conference abstract by Oct. 30 at 11:59 p.m. ET.
Don’t miss your chance to share your science on the world stage.
From bold ideas to lifesaving breakthroughs, your research starts here. Grant applications are open to help you shape the future of health.
October 20, 2025 at 9:00 PM
From bold ideas to lifesaving breakthroughs, your research starts here. Grant applications are open to help you shape the future of health.
The Health Innovation Pavilion is back at #AHA25 with three days of insightful panel discussions, live tech demos and the Health Tech Competition.
Stop by the Science & Technology Hall to see what’s next – and what’s possible in cardiovascular and digital health.
See you in New Orleans!
Stop by the Science & Technology Hall to see what’s next – and what’s possible in cardiovascular and digital health.
See you in New Orleans!
October 13, 2025 at 1:00 PM
The Health Innovation Pavilion is back at #AHA25 with three days of insightful panel discussions, live tech demos and the Health Tech Competition.
Stop by the Science & Technology Hall to see what’s next – and what’s possible in cardiovascular and digital health.
See you in New Orleans!
Stop by the Science & Technology Hall to see what’s next – and what’s possible in cardiovascular and digital health.
See you in New Orleans!
3 out of 4 U.S. adults have reversible CKM syndrome, but care is often fragmented and treatment delayed. Ready to learn more about cardiovascular-kidney-metabolic health for your patients? Add these sessions to your #AHA25 planner. ⬇️
October 8, 2025 at 4:00 PM
3 out of 4 U.S. adults have reversible CKM syndrome, but care is often fragmented and treatment delayed. Ready to learn more about cardiovascular-kidney-metabolic health for your patients? Add these sessions to your #AHA25 planner. ⬇️
Get expert insights in interventional cardiology through TCT at AHA. We’re excited to once again welcome the Cardiovascular Research Foundation to Scientific Sessions. Join us at #AHA25 and be part of the future of cardiovascular innovation and research.
October 7, 2025 at 4:00 PM
Get expert insights in interventional cardiology through TCT at AHA. We’re excited to once again welcome the Cardiovascular Research Foundation to Scientific Sessions. Join us at #AHA25 and be part of the future of cardiovascular innovation and research.
What’s new at Scientific Sessions 2025?
👉 Four full days of programming
👉 More immersive experiences in AI, simulation, and hands-on innovation
👉 More basic science sessions featuring the latest in scientific discovery
👉 Scientific Sessions OnDemand is now a built-in member benefit
👉 Four full days of programming
👉 More immersive experiences in AI, simulation, and hands-on innovation
👉 More basic science sessions featuring the latest in scientific discovery
👉 Scientific Sessions OnDemand is now a built-in member benefit
September 26, 2025 at 5:00 AM
What’s new at Scientific Sessions 2025?
👉 Four full days of programming
👉 More immersive experiences in AI, simulation, and hands-on innovation
👉 More basic science sessions featuring the latest in scientific discovery
👉 Scientific Sessions OnDemand is now a built-in member benefit
👉 Four full days of programming
👉 More immersive experiences in AI, simulation, and hands-on innovation
👉 More basic science sessions featuring the latest in scientific discovery
👉 Scientific Sessions OnDemand is now a built-in member benefit